Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Tibbitts DC
  • Escamilla-Powers JR
  • Zhang X
  • Sears RC
  • MESH
  • Animals
  • Enzyme Inhibitors
  • Female
  • Humans
  • Imidazoles
  • Leukemia, Myeloid, Acute
  • Protein-Serine-Threonine Kinases
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-pim-1
  • Pyridazines

Unbound MEDLINE

Studying c-Myc serine 62 phosphorylation in leukemia cells: concern over antibody cross-reactivity.

Links

  • Publisher Full Text
  • Authors

    Tibbitts DC, Escamilla-Powers JR, Zhang X, Sears RC

    Source

    Blood 119:22 2012 May 31 pg 5334-5

    MeSH

    Animals
    Enzyme Inhibitors
    Female
    Humans
    Imidazoles
    Leukemia, Myeloid, Acute
    Protein-Serine-Threonine Kinases
    Proto-Oncogene Proteins
    Proto-Oncogene Proteins c-pim-1
    Pyridazines

    Pub Type(s)

    Comment
    Letter
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22653959

    Related Citations

    • Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia.
    • Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.
    • Targeting PIM kinase activity significantly augments the efficacy of cytarabine.
    • The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells.
    • Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
    • Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.
    • A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.
    • 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved